Dual Modes of Cdc42 Recycling Fine-Tune Polarized Morphogenesis

被引:102
|
作者
Slaughter, Brian D. [1 ]
Das, Arupratan [1 ]
Schwartz, Joel W. [1 ]
Rubinstein, Boris [1 ]
Li, Rong [1 ,2 ]
机构
[1] Stowers Inst Med Res, Kansas City, MO 64110 USA
[2] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA
基金
美国国家卫生研究院;
关键词
FLUORESCENCE FLUCTUATION SPECTROSCOPY; GDP DISSOCIATION INHIBITOR; GTP-BINDING PROTEINS; CELL POLARITY; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CONJUGATED CONCANAVALIN; CROSS-CORRELATION; IN-VIVO; RHO GDI;
D O I
10.1016/j.devcel.2009.10.022
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In budding yeast, the highly conserved small GTPase Cdc42 localizes to the cortex at a cell pole and orchestrates the trafficking and deposition of cell surface materials required for building a bud or mating projection (shmoo). Using a combination of quantitative imaging and mathematical modeling, we elucidate mechanisms of dynamic recycling of Cdc42 that balance diffusion. Rdi1, a guanine nucleotide dissociation inhibitor (GDI), mediates a fast recycling pathway, while actin patch-mediated endocytosis accounts for a slower one. These recycling mechanisms are restricted to the same region of the nascent bud, as both are coupled to the Cdc42 GTPase cycle. We find that a single dynamic parameter, the rate of internalization inside the window of polarized delivery, is tuned to give rise to distinct shapes of Cdc42 distributions that correlate with distinct morphogenetic fates, such as the formation of a round bud or a pointed shmoo.
引用
收藏
页码:823 / 835
页数:13
相关论文
共 50 条
  • [31] Live Cell Fluorescence Analysis and Mathematical Modeling of Dual Mechanisms of Cdc42 Recycling in Yeast: Relationship of Internalization Rate and Morphology
    Slaughter, Brian D.
    Das, Arupratan
    Rubinstein, Boris
    Unruh, Jay
    Schwartz, Joel W.
    Li, Rong
    BIOPHYSICAL JOURNAL, 2010, 98 (03) : 749A - 749A
  • [32] PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42
    Martin-Belmonte, Fernando
    Gassama, Ama
    Datta, Anirban
    Yu, Wei
    Rescher, Ursula
    Gerke, Volker
    Mostov, Keith
    CELL, 2007, 128 (02) : 383 - 397
  • [33] Group I and II mammalian PAKs have different modes of activation by Cdc42
    Baskaran, Yohendran
    Ng, Yuen-Wai
    Selamat, Widyawilis
    Ling, Felicia Tay Pei
    Manser, Ed
    EMBO REPORTS, 2012, 13 (07) : 653 - 659
  • [34] Role of Rho-family GTPase Cdc42 in polarized expression of lymphocyte appendages.
    Ratner, S
    Piechocki, MP
    Galy, A
    FASEB JOURNAL, 2000, 14 (06): : A1144 - A1144
  • [35] Polarized Cdc42 activation promotes polar body protrusion and asymmetric division in mouse oocytes
    Dehapiot, Benoit
    Carriere, Virginie
    Carroll, John
    Halet, Guillaume
    DEVELOPMENTAL BIOLOGY, 2013, 377 (01) : 202 - 212
  • [36] Tuba, a Cdc42 GEF, is required for polarized spindle orientation during epithelial cyst formation
    Qin, Yi
    Meisen, Walter H.
    Hao, Yi
    Macara, Ian G.
    JOURNAL OF CELL BIOLOGY, 2010, 189 (04): : 661 - 669
  • [37] RacA and Cdc42 regulate polarized growth and microsclerotium formation in the dimorphic fungus Nomuraea rileyi
    Jiang, Sha-sha
    Yin, You-ping
    Song, Zhang-yong
    Zhou, Gui-lin
    Wang, Zhong-kang
    RESEARCH IN MICROBIOLOGY, 2014, 165 (03) : 233 - 242
  • [39] Two CDC42 paralogues modulate Cryptococcus neoformans thermotolerance and morphogenesis under host physiological conditions
    Ballou, Elizabeth R.
    Nichols, Connie B.
    Miglia, Kathleen J.
    Kozubowski, Lukasz
    Alspaugh, J. Andrew
    MOLECULAR MICROBIOLOGY, 2010, 75 (03) : 763 - 780
  • [40] Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer
    Humphries-Bickley, Tessa
    Castillo-Pichardo, Linette
    Hernandez-O'Farrill, Eliud
    Borrero-Garcia, Luis D.
    Forestier-Roman, Ingrid
    Gerena, Yamil
    Blanco, Manuel
    Rivera-Robles, Michael J.
    Rodriguez-Medina, Jose R.
    Cubano, Luis A.
    Vlaar, Cornelis P.
    Dharmawardhane, Suranganie
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (05) : 805 - 818